Evergreen Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,317
Closed -$254K 882
2023
Q4
$254K Buy
2,317
+133
+6% +$13.8K 0.01% 669
2023
Q3
$221K Sell
2,184
-318
-13% -$36.5K 0.01% 672
2023
Q2
$340K Buy
2,502
+530
+27% +$64.7K 0.01% 510
2023
Q1
$205K Buy
+1,972
New +$191K 0.01% 652

Other funds holding CNMD

Evergreen Capital Management's CNMD Position: Q1 2024 in Review

Evergreen Capital Management sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,317 shares — an estimated $254K sold.

Evergreen Capital Management first reported a position in CNMD in Q1 2023 and held it in 4 quarters. The position peaked at $340K in Q2 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Evergreen Capital Management reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Evergreen Capital Management sold 2,317 CONMED shares in Q1 2024, an estimated $254K.
  • Evergreen Capital Management first reported a position in CONMED in Q1 2023 and held it in 4 quarters.
  • Evergreen Capital Management's CONMED position peaked at $340K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Evergreen Capital Management's 13F filing for Q1 2024, filed 15 May 2024.